Gallium-68-tilmanocept is a special imaging agent used in this study. It helps doctors see the lymph nodes more clearly during a PET/CT scan. This is important for patients with certain types of endometrial cancer, as it helps in mapping the sentinel lymph nodes, which are the first few lymph nodes where cancer is likely to spread. This imaging agent is used to check if the cancer has spread to these lymph nodes, which can help in planning the best treatment approach.

Endometrial Cancer – This is a type of cancer that begins in the lining of the uterus, known as the endometrium. It is most commonly diagnosed in women who have gone through menopause. The disease often presents with abnormal vaginal bleeding, which prompts further investigation. As it progresses, the cancer can invade deeper layers of the uterus and may spread to nearby organs. Early detection is crucial as it typically starts in the inner lining and can be treated more effectively at this stage. The progression can vary, with some cases remaining localized while others may spread to lymph nodes or distant organs.

Uterine Cancer – This term generally refers to cancers that occur in the uterus, including endometrial cancer and other less common types like uterine sarcoma. Uterine cancer often presents with symptoms such as unusual vaginal bleeding or discharge, pelvic pain, or a mass. The disease can progress by invading the muscular layer of the uterus and potentially spreading to other parts of the body. It is most frequently diagnosed in postmenopausal women. The progression of uterine cancer can vary, with some types being more aggressive than others. Early detection and monitoring are important to manage the disease effectively.